Published in
American Society of Clinical Oncology, Journal of Clinical Oncology, 15_suppl(32), p. 3017-3017, 2014
DOI: 10.1200/jco.2014.32.15_suppl.3017
Links
Tools
Biomarker characterization using mass cytometry in a phase 1 trial of urelumab (BMS-663513) in subjects with advanced solid tumors and relapsed/refractory B-cell non-Hodgkin lymphoma.
Journal article published in 2014 by
Cariad Chester,
Serena Chang,
John F. Kurland,
Idit Sagiv-Barfi,
Debra Czerwinski,
Amanda Rajapaksa,
Erin Waller,
Mohith Sadaram,
Lori Richards,
Lewis J. Cohen,
Christoph Matthias Ahlers,
Maria Jure-Kunkel,
Holden Maecker,
Ronald Levy 
,
Holbrook Edwin Kohrt
,
Holbrook Edwin Kohrt
This paper is made freely available by the publisher.
Full text: Download
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 